Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in:

27.02.2024 | Maternal-Fetal Medicine

Does decreased fetal growth estimation in the appropriate for gestational age range affect delivery outcomes?

verfasst von: Michal Ovadia, Hadar Gluska, Gal Cohen, Hanoch Schreiber, Tal Biron-Shental, Michal Kovo, Gil Shechter-Maor

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To study the effect of decreased estimated fetal weight (EFW) percentiles in appropriate for gestational age fetuses.

Methods

This retrospective cohort study included women who had second and third trimester ultrasound examinations. Delivery and neonatal outcomes of pregnancies with decreased EFW of ≥  30 percentiles in EFW between ultrasound examinations (decreased growth group) and those without such a decrease (control group) were compared. Deliveries with EFW or birthweight below the 10th percentile were excluded.

Results

Among 1610 deliveries, 57 were in the decreased growth group and 1553 in the control group. Maternal characteristics did not differ between the groups except for higher rate of nulliparity in the decreased growth group. We found similar rates of Category II/III monitoring, cesarean deliveries due to non-reassuring fetal heart rate and adverse neonatal outcomes. Neonatal birthweight was lower in the decreased growth group as compared to controls.

Conclusions

This study did not find association between the group of appropriate for gestational age fetuses with decreased growth, with adverse outcomes.
Literatur
1.
2.
3.
4.
Gordijn SJ et al (2016) Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 48(3):333–339CrossRefPubMed
5.
Bardien N et al (2016) Placental insufficiency in fetuses that slow in growth but are born appropriate for gestational age: a prospective longitudinal study. PLoS ONE 11(1):e0142788CrossRefPubMedPubMedCentral
6.
Stratton JF et al (1995) Are babies of normal birth weight who fail to reach their growth potential as diagnosed by ultrasound at increased risk? Ultrasound Obstet Gynecol 5(2):114–118CrossRefPubMed
7.
MacDonald TM et al (2017) Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study. BMC Med 15(1):164CrossRefPubMedPubMedCentral
8.
Salafia CM, Charles AK, Maas EM (2006) Placenta and fetal growth restriction. Clin Obstet Gynecol 49(2):236–256CrossRefPubMed
9.
Brosens I, Puttemans P, Benagiano G (2019) Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes. Am J Obstet Gynecol 221(5):437–456
10.
Kovo M et al (2013) The placental factor in early- and late-onset normotensive fetal growth restriction. Placenta 34(4):320–324CrossRefPubMed
11.
Hendrix MLE et al (2019) Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight. Placenta 87:8–15CrossRefPubMed
12.
Hendrix MLE et al (2019) Reduced fetal growth velocities and the association with neonatal outcomes in appropriate-for-gestational-age neonates: a retrospective cohort study. BMC Preg Childbirth 19(1):31CrossRef
13.
Hadlock FP et al (1985) Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol 151(3):333–337CrossRefPubMed
14.
Dollberg S et al (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7(5):311–314PubMed
15.
Macones GA et al (2008) The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol 112(3):661–666CrossRefPubMed
16.
Bligh LN, Flatley CJ, Kumar S (2019) Reduced growth velocity at term is associated with adverse neonatal outcomes in non-small for gestational age infants. Eur J Obstet Gynecol Reprod Biol 240:125–129CrossRefPubMed
17.
Chatzakis C et al (2021) Perinatal outcome of appropriate-weight fetuses with decelerating growth. J Matern Fetal Neonatal Med 34(20):3362–3369CrossRefPubMed
18.
19.
Broere-Brown ZA et al (2019) Deceleration of fetal growth rate as alternative predictor for childhood outcomes: a birth cohort study. BMC Pregn Childbirth 19(1):216CrossRef
20.
Pedersen NG et al (2008) Early fetal size and growth as predictors of adverse outcome. Obstet Gynecol 112(4):765–771CrossRefPubMed
21.
Pedersen NG et al (2008) Fetal growth between the first and second trimesters and the risk of adverse pregnancy outcome. Ultrasound Obstet Gynecol 32(2):147–154CrossRefPubMed
22.
Kallen K (2004) Increased risk of perinatal/neonatal death in infants who were smaller than expected at ultrasound fetometry in early pregnancy. Ultrasound Obstet Gynecol 24(1):30–34CrossRefPubMed
Metadaten
Titel
Does decreased fetal growth estimation in the appropriate for gestational age range affect delivery outcomes?
verfasst von
Michal Ovadia
Hadar Gluska
Gal Cohen
Hanoch Schreiber
Tal Biron-Shental
Michal Kovo
Gil Shechter-Maor
Publikationsdatum
27.02.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-024-07432-2

Weitere Artikel der Ausgabe 3/2024

Small for gestational age in twin pregnancies and the risk of offspring pediatric neurologic morbidity

  • Maternal-Fetal Medicine

Correction: Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data

  • Correction

Obstetric cholestasis and its impact on the maternal outcome

  • Maternal-Fetal Medicine

Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data

  • Reply

The efficacy of levonorgestrelintrauterine system, drospirenone & ethinylestradiol tablets (II) and dydrogesterone in preventing the recurrence of endometrial polyps

  • General Gynecology

Subspecialty in obstetrics and gynecology: balancing focused surgical training and broad expertise

  • Letter to the Editor

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Keine eingeschränkten Kassenleistungen bei Schwangerschaft nach IVF

Nach privat bezahlter In-vitro-Fertilisation muss die gesetzliche Krankenkasse ein Arzneimittel zum Erhalt der Schwangerschaft bezahlen, so ein Urteil des Sozialgerichts in München.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise